Nonclinical Development of Next-generation Site-specific HER2-targeting Antibody–drug Conjugate (ARX788) for Breast Cancer Treatment
2020 · Molecular Cancer Therapeutics · 29 citations
https://doi.org/10.1158/1535-7163.mct-19-0692
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
278
Citations
10
h-index
10
i10-index
Prathap Nagaraja Shastri is an academic researcher. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & HER2/EGFR in Cancer Research & Acute Myeloid Leukemia Research. The author has an h-index of 10, co-authored 45 publications.
Click to start Chat